NCT06921902 Glycemic Metrics and Patterns in People With and Without Prediabetes
| NCT ID | NCT06921902 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Abbott Diabetes Care |
| Condition | Pre Diabetes |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2025-02-28 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2025-02-28 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The FreeStyle Libre 3 Continuous Glucose Monitoring (FSL3) System is used to characterize the glycemic profiles of people with and without a prediabetes diagnosis.
Eligibility Criteria
Inclusion Criteria: * Subject must be at least 18 years of age. * Subject must be willing and able to provide written signed and dated informed consent. Exclusion Criteria: * Subject has a diagnosis of type 1 diabetes, type 2 diabetes, or gestational diabetes. * Subject is known to be currently practicing a low-carbohydrate or ketogenic diet at the time of enrollment. * Subject is known to be pregnant at the time of enrollment. * Subject has known allergy to medical grade adhesive, isopropyl alcohol and/or ethyl alcohol used to disinfect skin. * Subject is currently on any form of treatment indicated for the treatment of diabetes. * Subject is currently on any form of medication indicated for weight loss.
Contact & Investigator
Shridhara Karinka, PhD
STUDY CHAIR
Abbott Diabetes Care
Frequently Asked Questions
Who can join the NCT06921902 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pre Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06921902 currently recruiting?
Yes, NCT06921902 is actively recruiting participants. Contact the research team at adc.clinical@abbott.com for enrollment information.
Where is the NCT06921902 trial being conducted?
This trial is being conducted at Bend, United States.
Who is sponsoring the NCT06921902 clinical trial?
NCT06921902 is sponsored by Abbott Diabetes Care. The principal investigator is Shridhara Karinka, PhD at Abbott Diabetes Care. The trial plans to enroll 2,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.